Review of the Latest Innovations in Cardiovascular Disease Care with BIOMEDICA CRO – Your Trusted Partner in Preclinical Trials and Biological Specimens Supply🧬
According to the recent data, approximately 15 million cases of Stroke occur worldwide annually. This is especially concerning as up to 80% of first Strokes are considered preventable through proactive healthcare measures.
The American Stroke Association recently introduced the Predicting Risk of Cardiovascular Disease Events (PREVENT) risk calculator – a cutting-edge tool designed to improve preventive treatment decisions. This calculator estimates 10-year and 30-year risks for stroke and heart disease in individuals starting from age 30 – providing an earlier and more detailed risk assessment compared to the widely used Pooled Cohort Equations.
“The most effective way to reduce Stroke incidence and Stroke-related mortality is through primary prevention – preventing the first Stroke,” explains Cheryl D. Bushnell, professor of neurology at Wake Forest University School of Medicine, North Carolina.
For more information on these guidelines, kindly refer to the AHAIASA journal, article “2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association”.
With this post, we at BIOMEDICA CRO want to emphasize our readiness to assist our customers with research on various cardiovascular and other diseases. With extensive experience in collecting human biospecimens and comprehensive clinical data from both diseased and control subjects, we are pleased to provide the necessary cases for further research and advancements in preventive medicine.
Quick and Easy Access to Human Biological Specimens for Research on Cardiovascular Diseases and more🩸
BIOMEDICA CRO has provided both prospective and retrospective collections of the numerous human biospecimen types and associated clinical data since 2017. We manage our own network of 50+ direct contracts with hospitals in many therapeutic areas and are ready to make a new one if necessary.
The access to Cardiology and Neurology departments allows us to supply biospecimens from subjects with a variety of conditions, including but not limited to the following:
- Ischemic and Hemorrhagic strokes;
- Deep vein thrombosis (DVT);
- Pulmonary embolism (PE);
- Heart failure;
- Myocardial infarction;
- Myocarditis;
- Chronic ischemic heart disease;
- Hypertensive heart disease, etc.
Importantly, all biosamples & data are collected in adherence to the highest ethical standards, following approval from the Institutional Review Board or Independent Ethics Committee (IRB/IEC). All subjects provide informed consent by signing an Individual Consent Form (ICF) before participating in our projects.
📩 Please email us to start our collaboration and order biosamples at office@biomedica-cro.com.
We are here to make it easy for you to access human biospecimens and clinical data quickly and easily! This way, YOU can focus on SCIENCE while BIOMEDICA CRO takes care of the rest.
🌐 Click here to explore our extensive range of 17 000+ banked biological samples.
🚀 Follow us on LinkedIn to stay up-to-date with the latest advancements, industry news, and exclusive offers in the field of human biospecimen procurement.
Early identification and thorough research can pave the way for more effective prevention and management strategies. Explore BIOMEDICA CRO services and receive only high-quality biospecimens for Cardiovascular or other diseases research. Let’s work together to push the boundaries of innovation and make remarkable investigations!
